Compare · AKUS vs ZONE

AKUS vs ZONE

Side-by-side comparison of Akouos Inc. (AKUS) and Zone Frontier Inc. (ZONE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKUS and ZONE operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
  • ZONE carries a market cap of $26.8M.
  • ZONE has hit the wire 8 times in the past 4 weeks while AKUS has been quiet.
  • AKUS has more recent analyst coverage (1 ratings vs 0 for ZONE).
MetricAKUSZONE
Company
Akouos Inc.
Zone Frontier Inc.
Price
-
-
Market cap
-
$26.8M
1M return
-
-
1Y return
-
-
Industry
Specialty Chemicals
Specialty Chemicals
Exchange
NASDAQ
AMEX
IPO
2020
2024
News (4w)
0
8
Recent ratings
1
0
AKUS

Akouos Inc.

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.

ZONE

Zone Frontier Inc.

Zone Frontier Inc. (NYSE AMERICAN: ZONE) is helping to build the critical infrastructure that powers the AI economy. Through a growing pipeline of projects, the Company aims to help meet the increasing demand for compute capacity, power, and digital infrastructure required by the world's leading AI companies.